Learn

Australia has among the world’s highest incidence of prostate cancer, with about one in six men diagnosed by the age of 85 years. At present, the prostate cancer 5‐year survival rate in Australia is 96%, which has significantly improved from 60% in the previous 30 years.

Technological advances have ushered a paradigm shift in the understanding, detection and management of prostate cancer in Australia, transitioning from overdetection and overtreatment to the use of sophisticated detection and treatment methods focused on harm minimisation. As such, there are fewer unnecessary biopsies, safer biopsy experiences, and a higher likelihood of active surveillance for low and intermediate risk disease, reducing harms.

This MJA narrative review shares more.

Details

• Explain key components of the narrative review.
• List main findings.
• Recognise changes in the approach to prostate cancer detection and management.

Authors: Isabella SC Williams, Aoife McVey, Sachin Perera, Jonathan S O’Brien, Louise Kostos, Kenneth Chen, Shankar Siva, Arun A Azad, Declan G Murphy, Veeru Kasivisvanathan, Nathan Lawrentschuk and Mark Frydenberg

Article Type: Narrative review